Cardlytics
CDLX
70 hedge funds and large institutions have $25.1M invested in Cardlytics in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 26 reducing their positions, and 19 closing their positions.
174% more call options, than puts
Call options by funds: $1.57M | Put options by funds: $573K
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.24% less ownership
Funds ownership: 4.27% → 4.04% (-0.24%)
14% less funds holding
Funds holding: 81 → 70 (-11)
42% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 19
46% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 26
55% less capital invested
Capital invested by funds: $55.3M → $25.1M (-$30.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$986K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$551K |
| 3 |
6CM
683 Capital Management
New York
|
+$348K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$322K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$261K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
-$985K |
| 2 |
Morgan Stanley
New York
|
-$748K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$421K |
| 4 |
GIPM
G2 Investment Partners Management
New York
|
-$311K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$293K |
CDLX Hedge Fund Activity: Q4 2025 in Review
70 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q4 2025, worth a combined $25.1M — down 55% from $55.3M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of CDLX and 11 opened new positions — a net loss of 8 holders — while 26 trimmed existing stakes and 14 added.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $986K. The largest seller was Quinn Opportunity Partners, cutting an estimated $985K.
- 70 institutional investors held Cardlytics (CDLX) as of Q4 2025, down from 81 in Q3 2025.
- Funds reported $25.1M of Cardlytics stock for Q4 2025, down 55% quarter-over-quarter.
- 11 funds opened new Cardlytics positions in Q4 2025 and 19 closed out, a net change of -8 holders.
- The largest Cardlytics buyer in Q4 2025 was Jacobs Levy Equity Management, an estimated $986K added.
- The largest Cardlytics seller in Q4 2025 was Quinn Opportunity Partners, an estimated $985K sold.
Based on aggregated 13F filings for Q4 2025.